Lungpacer News & Media
Stay up to date with the latest breakthroughs,
research, and company milestones
Lungpacer Press Release
Lungpacer Medical Announces First Patient Enrollment in AERO-PAS Post-Approval Study of the AeroPace® System
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again.
Read The Article
Lungpacer Press Release
Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again.
Read The Article
Lungpacer News
Health-Economic Value of Transvenous Diaphragm Neurostimulation in Ventilator Weaning
Read The Article
Sort by:
Lungpacer Announces CMS NTAP Approval for AeroPace<sup>®</sup> System in FY2026 IPPS Final Rule
August 14, 2025
Press Release
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace<sup>®</sup> System’s Breakthrough Results in Ventilator Weaning
June 12, 2025
Press Release
Harmony, Lungpacer, Verrica and Arbutus make C-suite hires
April 1, 2025
News
Lungpacer Medical Names Kevin Kearney as Chief Commercial Officer
March 27, 2025
News
To Prep for First Product Launch, Exton’s Lungpacer Medical Doubles Workforce
March 27, 2025
News
Lungpacer Medical names Kevin Kearney as CCO
March 25, 2025
News
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
March 24, 2025
Press Release
Lungpacer wins FDA IDE for AeroNova system
March 10, 2025
News
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
March 10, 2025
Press Release
